New Key Statistics Module, Z-Score and F-Score
OTCPK:BOVNF Key Ratios
Market Cap $ M | 269.75 |
Enterprise Value $ M | 170.95 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 4.94 |
Price/Book | 2.59 |
Price/Sales | 54.06 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4.00 |
EPS (TTM) $ | -0.55 |
Beneish M-Score | -3.39 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 25.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.63 |
EV-to-EBITDA | -4.86 |
PEG | -- |
Shares Outstanding M | 65.80 |
Net Margin (%) | -728.10 |
Operating Margin % | -817.52 |
Pre-tax Margin (%) | -727.60 |
Quick Ratio | 12.18 |
Current Ratio | 12.30 |
ROA % (ttm) | -27.35 |
ROE % (ttm) | -29.40 |
ROIC % (ttm) | -132.87 |
Dividend Yield % | -- |
Altman Z-Score | 16.85 |
BOVNF Number of Guru Trades
BOVNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BOVNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BOVNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioInvent International AB Insider Transactions
No Available Data
News about OTCPK:BOVNF
Total 0- 1